Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/23 16:15 | 12/15/23 | ATNF | Health | Drug | Pharmaceutical Preparations | Woody James N. | CA | DO | CEO | 2 | P | 46 | 0.7062 | 0 | 65 | 999% | 67 | D | ||||||||||||||
6/2/23 08:00 | 6/1/23 | ATNF | Health | Drug | Pharmaceutical Preparations | Steinman Lawrence | CA | D | 1 | P | 22 | 1.23 | 0 | 18 | 60 | 48 | D | |||||||||||||||
6/1/23 08:00 | 5/31/23 | ATNF | Health | Drug | Pharmaceutical Preparations | McGovern Jr. Donald A. | CA | D | 2 | P.m | 28 | 1.11 | 0 | 25 | 490 | 30 | D | |||||||||||||||
5/19/23 08:45 | 5/18/23 | ATNF | Health | Drug | Pharmaceutical Preparations | Marrone Pamela G | CA | D | 1 | P | 8 | 1.06 | 0 | 7 | 131 | 12 | D | |||||||||||||||
5/19/23 08:30 | 5/18/23 | ATNF | Health | Drug | Pharmaceutical Preparations | Pamir Ozan | CA | O | CFO | 1 | P | 5 | 1.01 | 0 | 5 | 135 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |